Third-party tested and 99% purity confirmed by in-house HPLC
in the intestinal L-cells and brain, PCSK1 processing produces GLP-1 and GLP-2 as part of a larger proglucagon fragment
Current pharmacological treatments, and newest clinical developments, are largely based on hormonal manipulation. These are fraught with side effects and are limited to possibly providing pain relief but cannot cure the disease, noted
For women, 1,000-3,000 mg/day supports egg quality and mitochondrial energy production in maturing oocytes, which is particularly relevant for women over 35 experiencing age-related fertility decline
Potential Benefits of Low-Dose GLP-1 Blockers While research is still early, clinicians are exploring this therapy for individuals dealing with: Chronic low-grade inflammation Fatigue, joint stiffness, and inflammatory markers that remain elevated even with lifestyle interventions
Front Aging Neurosci 10:106 Frantseva MV, Velazquez JL, Hwang PA, Carlen PL (2000) Free radical production correlates with cell death in an in vitro model of epilepsy